Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Biomolecules

Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis

  • Stephen W. Harris1
  • Purnima Tyagi2,3
  • Robert C. Huebert2,3,4
4 affiliations
  1. 1Department of Internal Medicine, Wright State University, 30 E. Apple St., Suite 3290, Dayton, OH 45409, USA
  2. 2Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
  3. 3Gastroenterology Research Unit, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
  4. 4Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo Clinic and Foundation, 200 1st Street SW, Rochester, MN 55905, USA
Read full textPDFDOICite

Abstract

Chronic liver disease represents a substantial global health burden, yet effective anti-fibrotic therapies remain elusive, largely due to an incomplete understanding of extracellular matrix (ECM) remodeling. While historical research prioritized the role of matrix metalloproteinase (MMP) deficiency in fibrogenesis, clinical outcomes indicate that broad-spectrum MMP modulation is paradoxically ineffective. This review synthesizes current evidence to demonstrate that hepatic fibrosis is driven by a complex regulatory imbalance wherein tissue inhibitors of metalloproteinases (TIMPs) sustain a pathological microenvironment. We highlight that TIMPs facilitate fibrogenesis through two primary mechanisms: the inhibition of MMP-mediated ECM degradation and the suppression of apoptosis in activated hepatic stellate cells (HSCs), a process exacerbated by mechanotransduction-driven feedback loops. Importantly, we address the functional redundancy within the TIMP family, as evidenced by the progression of fibrosis in TIMP-1-deficient models, which challenges traditional linear regulatory paradigms. Ultimately, we propose that the future of fibrosis treatment necessitates a shift from broad-spectrum enzyme modulation toward precision molecular strategies, including small-molecule inhibition, antisense oligonucleotides, and epigenetic reprogramming aimed at restoring the physiological MMP/TIMP equilibrium within the fibrotic niche.

Related

  1. The core mechanism of traditional Chinese medicine in improving myocardial fibrosis: restoring the dynamic balance of mitochondrial quality control
    Minxin Li, Ping Ni, Haijun Ma +8
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Domain-Specific Cognitive Associations With Standing Balance in Multiple Sclerosis
    Patrick G. Monaghan, Michael VanNostrand, Taylor N. Takla +1
    International Journal of MS CarePeer-reviewedLicence not statedFull textGeneral medicinePMC
  3. Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis
    Céline‐Hivda Yegen, Zakaria Maakoul, Dominique Marchant +7
    Animal Models and Experimental MedicinePeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. NQO1 acts as a context-dependent regulator of oxidative stress and biliary fibrosis in primary sclerosing cholangitis
    Juhyun Kim, Seung Hee Woo, Da-Hyeun Yoon +3
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCEurope PMC
  5. Team sport as a potential context for interpersonal emotion regulation in early adolescence: a quasi-experimental comparison with individual exercise
    Xilin Li, Qiuping You, Yunfei Tao +2
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{harris2026tipping,
  title = {{Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis}},
  author = {Stephen W. Harris and Purnima Tyagi and Robert C. Huebert},
  journal = {Biomolecules},
  year = {2026},
  month = oct,
  doi = {10.3390/biom16101513},
  url = {https://www.mdpi.com/2218-273X/16/10/1513},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis
AU  - Stephen W. Harris
AU  - Purnima Tyagi
AU  - Robert C. Huebert
PY  - 2026
DA  - 2026/10/01
JO  - Biomolecules
DO  - 10.3390/biom16101513
UR  - https://www.mdpi.com/2218-273X/16/10/1513
AB  - Chronic liver disease represents a substantial global health burden, yet effective anti-fibrotic therapies remain elusive, largely due to an incomplete understanding of extracellular matrix (ECM) remodeling. While historical research prioritized the role of matrix metalloproteinase (MMP) deficiency in fibrogenesis, clinical outcomes indicate that broad-spectrum MMP modulation is paradoxically ineffective. This review synthesizes current evidence to demonstrate that hepatic fibrosis is driven by a complex regulatory imbalance wherein tissue inhibitors of metalloproteinases (TIMPs) sustain a pathological microenvironment. We highlight that TIMPs facilitate fibrogenesis through two primary mechanisms: the inhibition of MMP-mediated ECM degradation and the suppression of apoptosis in activated hepatic stellate cells (HSCs), a process exacerbated by mechanotransduction-driven feedback loops. Importantly, we address the functional redundancy within the TIMP family, as evidenced by the progression of fibrosis in TIMP-1-deficient models, which challenges traditional linear regulatory paradigms. Ultimately, we propose that the future of fibrosis treatment necessitates a shift from broad-spectrum enzyme modulation toward precision molecular strategies, including small-molecule inhibition, antisense oligonucleotides, and epigenetic reprogramming aimed at restoring the physiological MMP/TIMP equilibrium within the fibrotic niche.
SN  - 2218-273X
ER  -